www.canadianrxpharmacy.org
- US Toll free:
- Regular US:
- UK:
- Categories list
-
- Alcoholism
- Alzheimer's And Parkinson's
- Analgesics
- Anti-inflammatories
- Antiallergic
- Antibiotics
- Anticonvulsants
- Antidepressants
- Antifungals
- Antiparasitic
- Antivirals
- Arthritis
- Asthma
- Birth Control
- Cancer
- Cardiovascular Diseases
- Cholesterol
- Diabetes
- Diuretics
- Erectile Dysfunction
- Eye Care
- Gastrointestinal Tract
- HIV
- Hypertension
- Men's Health
- Mental Disorders
- Migraine
- Muscle Relaxants
- Neurological Disorders
- Obesity
- Osteoporosis
- Respiratory Tract
- Skin Care
- Surgery
- Urinary Tract
- Women's Health
Generic Tizanidine - Zanaflex, Luvox, Zyrtec-d
$1.29
Buy now!
Generic Zyrtec-d
Cetirizine-pseudoephedrine 5mg
Zyrtec-D contains the same antihistamine found in regular Zyrtec, plus the decongestant pseudoephedrine. Zyrtec-D is prescribed to relieve the symptoms of hay fever and similar allergies, whether seasonal or year-round.
$0.60
Buy now!
Choose Your language:
- Testimonials
-
I received a partial shipment yesterday.
Read more »
The pills have always worked very well...as expected.
That's why I ordered from you again this year...just like last year.
In fact, yours work better than the 50 mg brand name pills I still have!!
An since your pills are scored (unlike the brand name ones that I have to use a knife to split), I can easily lower the dosage to 25 mg...which is all I need.
Thank you for a great product at a reasonable price!
- News
-
- FDA approved Tadalafil medication for the treatment of erectile dysfunction accompanied with primary and secondary symptoms of benign prostatic hyperplasia (BPH) in men above 45 years.
- Considering the information of three randomized, multicenter, double, blind clinical studies and a retrospective analysis of the medical documentation, FDA approved on October 7, 2011 Tadalafil medication for the treatment of erectile dysfunction accompanied with primary and secondary symptoms of benign prostatic hyperplasia (BPH) in men above 45 years
- The forming, development and monitoring of the pharmaceutical market in USA in September 2011
- In spite of low rates and stagnation of industrial development, the pharmaceutical market shows a dynamical growth
- Sildenafil citrate and pulmonary arterial hypertension
- Pulmonary arterial hypertension Definition “pulmonary arterial hypertension” is related to a group of diseases characterized by: - Progressive increase in pulmonary vascular resistance; - Reduction in pulmonary bloodflow; - High pulmonary artery pressure; - Contractility of the heart right ventricle; - Right ventricular failure
- Fruit and vegetables do not reduce overall cancer risk, review concludes
- Eating lots of fruit and vegetables will do little to reduce your risk of developing cancer, according to a review of a decade of research involving more than a million people
- Common painkillers could be linked to male reproductive disorder
- The use of mild painkillers, such as paracetamol, in pregnancy – previously considered harmless to the baby in the womb – could be a major factor in the rise of male reproductive disorders, according to a study
-
- Study Confirms Marijuana Helps in MS - MedPage Today
- MedPage TodayStudy Confirms Marijuana Helps in MSMedPage Today'It is worth noting that conventional treatments, such as baclofen and tizanidine hydrochloride, may also affect cognition, although published data are scarce,' they added
- Using Muscle Relaxants in Chronic Pain - Medscape
- Using Muscle Relaxants in Chronic PainMedscapeThe antispasticity medication tizanidine is sold under the brand name Zanaflex
- Acorda Therapeutics Reports First Quarter 2012 Financial Results - MarketWatch (press release)
- Acorda Therapeutics Reports First Quarter 2012 Financial ResultsMarketWatch (press release)Revenue from the sale of authorized generic tizanidine hydrochloride capsules to Watson totaled $1
- Acorda Therapeutics to Host Conference Call to Discuss First Quarter 2012 ... - MarketWatch (press release)
- Acorda Therapeutics to Host Conference Call to Discuss First Quarter 2012
- Acorda Therapeutics Reports First Quarter 2012 Financial Results - EON: Enhanced Online News (press release)
- Acorda Therapeutics Reports First Quarter 2012 Financial ResultsEON: Enhanced Online News (press release)ZANAFLEX CAPSULES ® (tizanidine hydrochloride), ZANAFLEX ® (tizanidine hydrochloride) tablets and authorized generic capsules net revenue and royalties - For the quarter ended March 31, 2012, the Company reported combined net revenue from ZANAFLEX
 |
Bookmark this site |
|---|
 |
Subscribe to the News |
|---|
